Study Title: Anticancer potential of (−)-epicatechin in a triple-negative mammary gland model
Citation: Almaguer et al., 2021 · Journal of Pharmacy and Pharmacology
What the Study Found: (−)-Epicatechin demonstrated anticancer activity in a triple-negative mammary gland model, reducing tumor growth and metastatic potential. It modulated pathways involved in cell proliferation, survival, and mitochondrial function. The flavanol showed promising effects without apparent toxicity to normal tissue.
What this means in real life: Triple-negative breast cancer is particularly aggressive and often linked to high mitochondrial stress and altered energy metabolism. This study highlights (−)-epicatechin’s ability to target those pathways, slowing cancer progression at the cellular energy level. Mitochondrial support offers a complementary approach that may help the body maintain healthier energy balance during cancer-related challenges.
Contenu associé
- Curious how mitochondrial health intersects with cancer biology and recovery? → Cancer, Cellular Energy, and Mitochondria: Understanding the Biology Beneath the Surface
- Want to understand mitochondrial health in cancer recovery? → Mitochondrial Health in Cancer Recovery: Why Cellular Energy Matters After Treatment
- Looking for ways to support mitochondrial function daily? → How to Repair and Maintain Mitochondrial Health Naturally